Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck
- PMID: 16549836
- DOI: 10.1200/JCO.2005.04.6052
Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck
Abstract
Purpose: To determine how to use node response on computed tomography (CT) to indicate the need for neck dissection.
Patients and methods: Five hundred fifty patients with lymph node-positive head and neck cancer were treated between 1990 and 2002 with radiotherapy (RT) at a median dose of 74.4 Gy; 24% of these patients (n = 133) were treated with chemotherapy. Three hundred forty-one patients (62%) underwent planned post-RT neck dissection. Physical examination and contrast-enhanced CT were performed 30 days after completion of RT. CT images were reviewed in 211 patients for lymph node size (largest axial dimension) and presence of a focal abnormality (lucency, enhancement, or calcification). By correlating post-RT CT to neck dissection pathology, criteria associated with a low likelihood of residual disease were identified. A subset of patients who fit these criteria of radiographic response who did not undergo post-RT neck dissection was observed for recurrence.
Results: Radiographic complete response (rCR) was defined as the absence of any large (> 1.5 cm) or focally abnormal lymph node. Correlation of response with neck dissection pathology indicated a negative predictive value of 77% for complete clinical response and 94% for rCR. In 32 patients (median follow-up time, 3.2 years) with rCR who did not undergo post-RT neck dissection, the 5-year ultimate neck control rate (100%) and cause-specific survival rate (72%) were not significantly different from the rates of patients with a negative post-RT neck dissection.
Conclusion: Patients with rCR 4 weeks after RT can be spared from a post-RT neck dissection regardless of initial node stage.
Similar articles
-
Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection?Cancer. 2008 Mar 1;112(5):1076-82. doi: 10.1002/cncr.23279. Cancer. 2008. PMID: 18186495
-
The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):991-9. doi: 10.1016/j.ijrobp.2005.03.066. Epub 2005 Aug 15. Int J Radiat Oncol Biol Phys. 2005. PMID: 16099601
-
Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma.Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):420-8. doi: 10.1016/s0360-3016(01)02603-7. Int J Radiat Oncol Biol Phys. 2002. PMID: 11872288
-
Controversies in surgical management of the node-positive neck after chemoradiation.Semin Radiat Oncol. 2009 Jan;19(1):24-8. doi: 10.1016/j.semradonc.2008.09.005. Semin Radiat Oncol. 2009. PMID: 19028342 Review.
-
Management of the clinically negative (N0) neck.Curr Oncol Rep. 2002 Jan;4(1):81-6. doi: 10.1007/s11912-002-0052-9. Curr Oncol Rep. 2002. PMID: 11734118 Review.
Cited by
-
Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.Head Neck. 2013 Feb;35(2):294-306. doi: 10.1002/hed.21975. Epub 2012 Jan 27. Head Neck. 2013. PMID: 22287320 Free PMC article. Review.
-
Neck control after definitive radiochemotherapy without planned neck dissection in node-positive head and neck cancers.BMC Cancer. 2012 Feb 7;12:59. doi: 10.1186/1471-2407-12-59. BMC Cancer. 2012. PMID: 22313843 Free PMC article.
-
Head and neck cancer: how imaging predicts treatment outcome.Cancer Imaging. 2006 Oct 31;6(Spec No A):S145-53. doi: 10.1102/1470-7330.2006.9028. Cancer Imaging. 2006. PMID: 17114069 Free PMC article.
-
Positron emission tomography for neck evaluation following definitive treatment with chemoradiotherapy for locoregionally advanced head and neck squamous cell carcinoma.Rev Recent Clin Trials. 2012 Feb;7(1):36-41. doi: 10.2174/157488712799363226. Rev Recent Clin Trials. 2012. PMID: 21864252 Free PMC article. Review.
-
Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129.Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):362-371. doi: 10.1016/j.ijrobp.2016.05.026. Epub 2016 May 28. Int J Radiat Oncol Biol Phys. 2016. PMID: 27478170 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical